Winfield Associates’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
-87
Closed -$28K 176
2017
Q4
$28K Sell
87
-196
-69% -$62.9K 0.01% 254
2017
Q3
$89K Sell
283
-92
-25% -$27.2K 0.05% 152
2017
Q2
$102K Sell
375
-92
-20% -$24.3K 0.06% 148
2017
Q1
$128K Buy
467
+67
+17% +$18.9K 0.07% 137
2016
Q4
$113K Sell
400
-40
-9% -$11.9K 0.07% 139
2016
Q3
$138K Buy
440
+40
+10% +$11.8K 0.09% 126
2016
Q2
$97K Sell
400
-20
-5% -$5.27K 0.06% 140
2016
Q1
$109K Buy
420
+20
+5% +$5.28K 0.07% 128
2015
Q4
$123K Hold
400
0.08% 126
2015
Q3
$117K Sell
400
-100
-20% -$33K 0.09% 124
2015
Q2
$202K Buy
500
+200
+67% +$80.3K 0.14% 109
2015
Q1
$127K Buy
300
+200
+200% +$78.8K 0.09% 128
2014
Q4
$34K Hold
100
0.03% 178
2014
Q3
$33K Hold
100
0.02% 179
2014
Q2
$31K Sell
100
-50
-33% -$15K 0.02% 190
2014
Q1
$46K Buy
+150
New +$47.6K 0.04% 162

Other funds holding BIIB